| Psychophysical Correlates of Pain Reduction by Topical Analgesic Compounds (NCT02322164) | National Center for Complementary and Integrative Health (NCCIH) | 2014-12-19 |
| Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001) (NCT02341599) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-12-11 |
| A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone (NCT02730689) | Alvogen Korea | 2014-12-01 |
| Effect of an Anti-ageing Supplement on Oxidative Stress (NCT03272867) | University Medical Center Groningen | 2014-12-01 |
| A Study of Lispro Formulations in Healthy Participants (NCT02293551) | Eli Lilly and Company | 2014-12-01 |
| DEtection of Cellular Inflammation With FERumoxytol in the HEART (NCT02319278) | University of Edinburgh | 2014-12-01 |
| Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics (NCT02579434) | Seoul National University Hospital | 2014-12-01 |
| Adalimumab PK Bioequivalence Study to EU and US Sourced Humira (NCT02472912) | Mylan Inc. | 2014-12-01 |
| A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease (NCT02323334) | Eli Lilly and Company | 2014-12-01 |
| Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548 (NCT02327546) | Akebia Therapeutics | 2014-12-01 |
| Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants (NCT05995691) | Amgen | 2014-11-24 |
| Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers (NCT02391181) | Azad Pharma AG | 2014-11-01 |
| Single-Dose Study of MT203 (NCT02354599) | Takeda | 2014-11-01 |
| A Study of LY2623091 in Healthy Participants (NCT02300259) | Eli Lilly and Company | 2014-11-01 |
| Effect of Intragastric Administration of Fatty Acids on Generalized Reward Sensitivity (NCT02984150) | Universitaire Ziekenhuizen KU Leuven | 2014-11-01 |
| Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort (NCT02286635) | PTC Therapeutics | 2014-11-01 |
| Optimal Low B-value in Intravoxel Incoherent Motion Diffusion-weighted MR Imaging of the Brain (NCT02411864) | Tang-Du Hospital | 2014-11-01 |
| Detecting Chronic Subdural Hematoma With Microwave Technology (NCT02282228) | Sahlgrenska University Hospital | 2014-11-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects (NCT02285465) | Astellas Pharma Europe B.V. | 2014-11-01 |
| AZD8108 SAD/MAD in Healthy Volunteers (NCT02248818) | AstraZeneca | 2014-11-01 |
| Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women (NCT00862433) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-10 |
| A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264) (NCT02229877) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-10-06 |
| DHB Supplement Interaction Study (NCT02257879) | National Institute of Environmental Health Sciences (NIEHS) | 2014-10-03 |
| Effects of Experimental Hyperketonemia on Myocardial Metabolism (NCT02814474) | University of Aarhus | 2014-10-01 |
| Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (NCT02268838) | Eisai Co., Ltd. | 2014-10-01 |
| A Study of LY3079514 in Healthy Participants (NCT02242903) | Eli Lilly and Company | 2014-10-01 |
| Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast (NCT02517372) | RSPR Pharma AB | 2014-10-01 |
| Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects (NCT02271113) | GlycoMimetics Incorporated | 2014-10-01 |
| Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion (NCT02347969) | Nutratech Conseils | 2014-10-01 |
| A Study of LY2835219 in Healthy Participants (NCT02256267) | Eli Lilly and Company | 2014-10-01 |
| A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants (NCT02271425) | Eli Lilly and Company | 2014-10-01 |
| A Bioequivalence Study Comparing Two Different Tafamidis Formulations (NCT02217813) | Pfizer | 2014-10-01 |
| PREPL in Health and Disease (NCT02263781) | Universitaire Ziekenhuizen KU Leuven | 2014-10-01 |
| Radiolabeled Study of CC-122 in Healthy Subjects (NCT02234999) | Celgene | 2014-09-23 |
| Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers (NCT02404870) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-09-16 |
| Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1 (NCT02243150) | G1 Therapeutics, Inc. | 2014-09-01 |
| E-NOSE for Breath Gas Analysis Under Microgravity Conditions (NCT02507622) | University Hospital, Caen | 2014-09-01 |
| Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers (NCT02227069) | Maruho North America Inc. | 2014-09-01 |
| Conflict Detection Development During the Reasoning (NCT02788968) | University Hospital, Caen | 2014-09-01 |
| Explore the Synergy of Combination TKI Therapy (NCT02129166) | University of Florida | 2014-09-01 |
| Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable (NCT02265783) | Medtronic - MITG | 2014-09-01 |
| A Study of How the Body Breaks Down and Eliminates LY2623091 (NCT02242981) | Eli Lilly and Company | 2014-09-01 |
| Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin (NCT01583634) | Mespere Lifesciences Inc. | 2014-09-01 |
| Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta (NCT02479646) | Mylan Inc. | 2014-09-01 |
| Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects (NCT02212821) | Universitaire Ziekenhuizen KU Leuven | 2014-09-01 |
| Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting (NCT02253056) | Charite University, Berlin, Germany | 2014-09-01 |
| A Study of Evacetrapib in Healthy Japanese Participants (NCT02226653) | Eli Lilly and Company | 2014-09-01 |
| Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers (NCT02256930) | Maruho North America Inc. | 2014-09-01 |
| Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects (NCT02254369) | GliaCure, Inc. | 2014-09-01 |
| TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study (NCT02252354) | Takeda | 2014-09-01 |
| Safety Study of Immune System Modulator for Autoimmune Diseases (NCT02243683) | Artax Biopharma Inc | 2014-09-01 |
| Food Effect on Pharmacokinetic Parameters of ABX464 (NCT02731885) | Abivax S.A. | 2014-09-01 |
| Validation of Methods for Evaluating Operation Force, Motion and Visual Perception in Weightlessness (NCT02508558) | University Hospital, Caen | 2014-09-01 |
| The Effect of Phenylephrine and Ephedrine on Microvascular Blood Flow (NCT02252627) | University of Nottingham | 2014-08-01 |
| A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects (NCT02240160) | GW Pharmaceuticals Ltd | 2014-08-01 |
| A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users (NCT02218021) | Alkermes, Inc. | 2014-08-01 |
| Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers (NCT02210247) | Pacira Pharmaceuticals, Inc | 2014-08-01 |
| Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2 (NCT02178059) | AstraZeneca | 2014-08-01 |
| Non-Invasive Respiratory Monitor (NCT02851043) | Nemours Children's Clinic | 2014-08-01 |
| Effectivity of Slackline-Training in Physiotherapy (NCT02218086) | THIM - die internationale Hochschule für Physiotherapie | 2014-08-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects (NCT02207595) | UCB Celltech | 2014-08-01 |
| Food Effect Study of AG-221 in Healthy Male Subjects (NCT02218346) | Agios Pharmaceuticals, Inc. | 2014-08-01 |
| Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers (NCT02792829) | Eisai Inc. | 2014-08-01 |
| Phase 1, TAK-648, Single-Rising Dose Study (NCT02684396) | Takeda | 2014-08-01 |
| Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function (NCT02187601) | Meridian Bioscience, Inc. | 2014-08-01 |
| Investigating the Physiology of Targeted Theta-burst Neuromodulation (NCT02616835) | Institute of Mental Health Nottingham | 2014-08-01 |
| Imaging Techniques in CT: Technical Development (NCT02242448) | National Institutes of Health Clinical Center (CC) | 2014-07-31 |
| Metabolic and Neural Adaptations to Weight Loss, Plateau, and Regain (NCT02199483) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-07-21 |
| Acid Pocket: Position and Aspiration (NCT02199002) | KU Leuven | 2014-07-01 |
| Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR (NCT02185066) | HK inno.N Corporation | 2014-07-01 |
| A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers (NCT02319148) | Pfizer | 2014-07-01 |
| Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab. (NCT02189733) | Ablynx, a Sanofi company | 2014-07-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days (NCT02140320) | Respivert Ltd | 2014-07-01 |
| Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935 (NCT02201056) | Takeda | 2014-07-01 |
| A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants (NCT02188303) | OPKO Health, Inc. | 2014-07-01 |
| A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects (NCT02213315) | MedImmune LLC | 2014-07-01 |
| Effects of THC and CBD on Human Episodic Memory Function (NCT02291562) | Central Institute of Mental Health, Mannheim | 2014-07-01 |
| Fludrocortisone in Healthy Volunteers (AFLUCO4) (NCT02140918) | Rennes University Hospital | 2014-07-01 |
| A Pharmacokinetic Drug Interaction and Tolerance Study of Paracetamol and Nefopam (NCT02174068) | University Hospital, Clermont-Ferrand | 2014-07-01 |
| Clinical Autonomic Disorders: A Training Protocol (NCT02154009) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-06-05 |
| Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001) (NCT02650895) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-06-02 |
| A Study of LY3050258 in Healthy Participants (NCT02121834) | Eli Lilly and Company | 2014-06-01 |
| Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects (NCT02206854) | Gerd Geisslinger | 2014-06-01 |
| Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2 (NCT02249728) | Prana Biotechnology Limited | 2014-06-01 |
| Phase 1 Safety and PK Study of OLT1177 Capsules (NCT02134964) | Olatec Therapeutics, Inc. | 2014-06-01 |
| Relative Bioavailability Study (NCT02159313) | Bayer | 2014-06-01 |
| A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants (NCT02156492) | Eli Lilly and Company | 2014-06-01 |
| Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants (NCT02161731) | Eli Lilly and Company | 2014-06-01 |
| Consumption of Dairy Yogurt Enhanced Immune Function (NCT02535663) | Yonsei University | 2014-06-01 |
| Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole (NCT02190708) | Vivoryon Therapeutics N.V. | 2014-06-01 |
| Bioequivalence Study of CJ-30059 (NCT02173912) | HK inno.N Corporation | 2014-06-01 |
| Food Effect and CYP1A2 Induction Study in Healthy Subjects (NCT02168205) | Celgene | 2014-05-30 |
| Relative Bioavailability Study of CC-292 (NCT02433457) | Celgene | 2014-05-26 |
| A Study of Cephalexin Suspension in Healthy Participants (NCT02123459) | Eli Lilly and Company | 2014-05-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects (NCT02136316) | Astellas Pharma Europe B.V. | 2014-05-01 |
| A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants (NCT02111083) | Eli Lilly and Company | 2014-05-01 |
| A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples (NCT02189330) | Pfizer | 2014-05-01 |
| A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293 (NCT02126514) | AstraZeneca | 2014-05-01 |
| To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers (NCT02140268) | Ardelyx | 2014-05-01 |
| Influence on Erythropoetin-level by Xenon (NCT02129400) | RWTH Aachen University | 2014-05-01 |